XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 166 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,897,565 | -9.4% | 48,668 | 0.0% | 0.02% | -23.8% |
| Q1 2024 | $2,095,157 | -54.3% | 48,668 | -51.1% | 0.02% | -60.4% |
| Q4 2023 | $4,585,641 | +437.0% | 99,558 | +298.2% | 0.05% | +430.0% |
| Q3 2023 | $854,000 | -56.7% | 25,000 | -50.0% | 0.01% | -70.6% |
| Q4 2022 | $1,971,500 | -16.9% | 50,000 | -23.9% | 0.03% | -22.7% |
| Q3 2022 | $2,372,000 | -22.0% | 65,698 | -34.3% | 0.04% | -13.7% |
| Q2 2022 | $3,042,000 | – | 100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |